Resources

The team recognized the need to further influence culture around AKI prevention, along with a new focus on minimizing outlier contrast volume as a strategy to improve AKI rate.

Clinical Practice Today features specialty-focused articles designed for physicians to sharpen diagnostic skills, improve patient outcomes, and stay current with best practices.

Explore Duke Health's clinical trial offerings to learn about new therapies, volunteer opportunities, and new advances in medicine.

The Duke Cancer Institute’s Conversations in Cancer video series examines key developments and emerging innovations in oncology.

View upcoming seminars, workshops, lectures, and public events hosted by the Duke Cancer Institute.

A list of public available resources, webinars, and conference information.

View Duke Health’s event calendar for referring physicians, including featured CME and specialty events.

Program Development

Launching a TAVR Program at Frye Regional Medical Center

Frye Regional Medical Center, in partnership with the Duke Heart Network, launched a local transcatheter aortic valve replacement (TAVR) program to enhance cardiovascular care and reduce patient travel. Despite pandemic challenges, the program successfully performed its first procedure in June 2024, achieving excellent clinical outcomes and serving 60 patients in its inaugural year.
Read More

Education

Events

Duke Cancer Network
Duke Debates: Discussions, expert panels, and debates covering Multiple Myeloma, CLL, Lymphoma, and Leukemias. Previous topics have included Clinical Quandaries, Meet the Expert, Cardio-Oncology, the Role of Surveillance Imaging, Vaccinations Post-BCMA Therapy, Sickle Cell Gene Therapy, and much…
Duke Cancer Network
This interactive and in-depth symposium equips Advanced Practice Providers and nurses to understand the complexities of cancer care and facilitates application of knowledge into real-world clinical cases.
Duke Cancer Network
This conference offers cutting-edge insights into emerging therapies for solid tumor cancers. Leading experts will present on clinical advances and practice use of bispecific drugs and antibody-drug conjugates (ADCs); as well as covering toxicity management, CNS complications, and real-world…